Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SANTE
NCT03909737Phase 4Active, not recruiting
- Sponsor
- University of Maryland, Baltimore
- Start
- Sep 2020
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of azithromycin in stillbirth and Infant mortality (IMR) (6 arms), sponsored by University of Maryland, Baltimore. Primary endpoints: Rate of stillbirths and infant mortality and Rate of infant mortality. Started Sep 2020; status: active, not recruiting.
02
Drugs
azithromycin
03
Conditions
stillbirthInfant mortality (IMR)
Beyond the preview
Go deeper on NCT03909737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03909737.